News

A psychiatrist discusses his favorite hobby of scuba diving.

"No matter where you are in your career, it is our generation of providers who have the opportunity to facilitate how the medicine of today evolves into the medicine of tomorrow."

Transcranial magnetic stimulation treatment appeared to lessen some neuropsychiatric symptoms of long COVID in an open-label pilot study.

Learn more about a comprehensive system of care for those who are in crisis and need immediate access to care, aided by the new 988 Suicide & Crisis Lifeline.

Fasedienol meets trial endpoints by reducing anxiety during public speaking simulations in patients with social anxiety disorder.

And the winner is…

According to the National Community Pharmacists Association, 97% of independent pharmacy owners reported shortages of Adderall in early 2023. As these shortages continue, here's how you can best support your patients with ADHD.

Emergency department records reveal that youth experiencing disrupted sleep are at greater risk for suicidal thoughts and behaviors.

In need of some late summer reading?

From overutilization of emergency departments to reversible clomiphene-associated manic episodes, here are highlights from the week in Psychiatric Times.

The FDA did not grant approval for the treatment for major depressive disorder.

It all makes sense.

A review of psychiatric referrals and mobile mental health interventions.

“Am I doing the right thing? Is this right for the community I am trying to serve?”

This book could be a resource for your patients with bipolar disorder…

What can we learn from sleep in schizophrenia? New research sheds light.

Synagogue shooter receives death penalty.

What risk does clomiphene use present to patients?

What does it mean to be creative?

One doctor addresses burnout through song.

Although ulotaront was well-tolerated, results for patients treated with it were not superior to those for patients treated with placebo.

The experts weighed in on a wide variety of psychiatric issues for the July 2023 issue of Psychiatric Times.

Have you seen the movie “Oppenheimer”?

The law says anyone under the age of 18 is considered “incompetent” in regard to health care decisions. But is this what’s best for treatment?

Take your pick...

We need to recognize prolonged grief disorder.

In the largest study of its kind to date, researchers found promising results for subcutaneous ketamine for treatment resistant depression.

A psychiatry resident from Mexico reflects on the field.

Introspections from an international resident following a US conference shed light on issues in geriatric psychiatry and more.

A new cognitive biotype for depression may impact symptoms and treatment outcomes.